Page last updated: 2024-09-03

olmesartan medoxomil and Cirrhosis, Liver

olmesartan medoxomil has been researched along with Cirrhosis, Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishikawa, H; Kurikawa, N; Kuroda, S; Suga, M; Yamada, K	1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Cirrhosis, Liver

Article	Year
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. British journal of pharmacology, 2003, Volume: 139, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Collagen; Hepatocytes; Imidazoles; Liver Cirrhosis; Male; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles	2003

Article

Year

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.

British journal of pharmacology, 2003, Volume: 139, Issue:6

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Collagen; Hepatocytes; Imidazoles; Liver Cirrhosis; Male; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles

2003